HIMS - Hims & Hers Health, Inc. Stock Price, Fair Value and News

11.90USD-0.44 (-3.57%)Market Closed

Market Summary

USD11.90-0.44

Market Closed

-3.57%

HIMS Alerts

6 major insider sales recently.

HIMS Stock Price

View Fullscreen

HIMS RSI Chart

HIMS Valuation

Market Cap

2.6B

Price/Earnings (Trailing)

-109.71

Price/Sales (Trailing)

2.96

EV/EBITDA

-206.26

Price/Free Cashflow

35.16

HIMS Price/Sales (Trailing)

HIMS Profitability

Operating Margin

81.99%

EBT Margin

-2.47%

Return on Equity

-6.84%

Return on Assets

-5.34%

Free Cashflow Yield

2.84%

HIMS Fundamentals

HIMS Revenue

Revenue (TTM)

872.0M

Rev. Growth (Yr)

47.5%

Rev. Growth (Qtr)

8.79%

HIMS Earnings

Earnings (TTM)

-23.5M

Earnings Growth (Yr)

111.41%

Earnings Growth (Qtr)

116.45%

Breaking Down HIMS Revenue

Last 7 days

-15.5%

Last 30 days

-21.1%

Last 90 days

48.3%

Trailing 12 Months

10.3%

How does HIMS drawdown profile look like?

HIMS Financial Health

Current Ratio

HIMS Investor Care

Shares Dilution (1Y)

2.36%

Diluted EPS (TTM)

-0.11

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	616.4M	710.7M	792.6M	872.0M
2022	320.9M	373.7M	444.4M	526.9M
2021	171.0M	195.8M	228.6M	271.9M
2020	99.1M	115.7M	132.2M	148.8M
2019	0	0	0	82.6M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Hims & Hers Health, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 15, 2024	boughton soleil	sold	-34,916	13.95	-2,503	chief legal officer
Apr 08, 2024	baird melissa	acquired	4,700	0.4	11,751	chief operating officer
Apr 08, 2024	baird melissa	sold	-173,254	14.7438	-11,751	chief operating officer
Apr 05, 2024	baird melissa	sold	-171,372	14.5836	-11,751	chief operating officer
Apr 05, 2024	baird melissa	acquired	4,700	0.4	11,751	chief operating officer
Apr 04, 2024	dudum andrew	sold	-2,134,620	14.7782	-144,444	chief executive officer
Apr 04, 2024	baird melissa	acquired	4,700	0.4	11,751	chief operating officer
Apr 04, 2024	dudum andrew	acquired	458,998	2.43	188,888	chief executive officer
Apr 04, 2024	dudum andrew	sold	-2,828,070	14.9722	-188,888	chief executive officer
Apr 04, 2024	baird melissa	sold	-174,933	14.8866	-11,751	chief operating officer

Which funds bought or sold HIMS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 18, 2024	Allspring Global Investments Holdings, LLC	reduced	-71.67	-197,243	191,348	-%
Apr 18, 2024	STATE OF MICHIGAN RETIREMENT SYSTEM	new	-	2,784,600	2,784,600	0.01%
Apr 18, 2024	Hexagon Capital Partners LLC	new	-	959	959	-%
Apr 18, 2024	CULLINAN ASSOCIATES INC	reduced	-24.98	269,028	1,154,060	0.06%
Apr 18, 2024	Capital Advisors, Ltd. LLC	unchanged	-	1,000	1,000	-%
Apr 16, 2024	FSC Wealth Advisors, LLC	sold off	-100	-445	-	-%
Apr 15, 2024	Counterpoint Mutual Funds LLC	new	-	284,602	284,602	0.07%
Apr 15, 2024	EXCHANGE TRADED CONCEPTS, LLC	new	-	22,865	22,865	-%
Apr 15, 2024	Concurrent Investment Advisors, LLC	new	-	124,574	124,574	0.01%
Apr 15, 2024	Sound Income Strategies, LLC	unchanged	-	1,314	3,094	-%

Are Funds Buying or Selling HIMS?

Are funds buying HIMS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own HIMS

No. of Funds

HIMS Alerts

6 major insider sales recently.

Unveiling Hims & Hers Health, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 29, 2024	institutional venture management xvi, llc	3.0%	6,222,558	SC 13D/A
Feb 14, 2024	abraham jack	4.6%	9,324,396	SC 13G/A
Feb 13, 2024	vanguard group inc	6.96%	14,173,285	SC 13G/A
Jan 31, 2024	blackrock inc.	5.3%	10,859,383	SC 13G
Jun 02, 2023	newview capital fund i, l.p.	2.0%	3,935,444	SC 13G/A
Mar 06, 2023	institutional venture management xvi, llc	3.9%	7,707,280	SC 13D/A
Mar 06, 2023	redpoint ventures vi, l.p.	3.8%	7,577,015	SC 13D/A
Mar 01, 2023	forerunner partners iii, l.p.	4.9%	9,756,893	SC 13D/A
Feb 14, 2023	newview capital fund i, l.p.	2.5%	5,053,698	SC 13G
Feb 13, 2023	abraham jack	6.0%	11,944,284	SC 13G/A

Recent SEC filings of Hims & Hers Health, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 16, 2024	4	Insider Trading
Apr 15, 2024	144	Notice of Insider Sale Intent
Apr 08, 2024	144	Notice of Insider Sale Intent
Apr 08, 2024	4	Insider Trading
Apr 08, 2024	4	Insider Trading
Apr 05, 2024	144	Notice of Insider Sale Intent
Apr 04, 2024	144	Notice of Insider Sale Intent
Apr 04, 2024	3	Insider Trading
Apr 03, 2024	8-K	Current Report
Apr 02, 2024	4	Insider Trading

Peers (Alternatives to Hims & Hers Health, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
PG	370.2B	83.9B	-2.77%	4.69%	25.07	4.41	4.55%	3.44%
CL	71.4B	19.5B	-2.32%	15.44%	31.03	3.67	8.29%	28.85%
EL	51.9B	15.2B	-0.92%	-43.56%	107.54	3.43	-7.33%	-68.01%
CHD	25.2B	5.9B	-1.56%	15.30%	33.3	4.29	9.16%	82.56%
CLX	17.8B	7.3B	-6.76%	-10.79%	222.17	2.43	3.47%	-81.61%
COTY	9.9B	6.0B	-7.30%	-11.03%	30.55	1.65	14.07%	132.95%
ELF	9.3B	890.1M	-12.14%	80.07%	71.87	10.45	79.24%	176.22%
MID-CAP
IPAR	4.0B	1.3B	-9.42%	-18.26%	25.99	3.01	21.26%	26.23%
NWL	2.9B	8.1B	-9.20%	-44.03%	-7.38	0.35	-14.02%	-296.95%
HIMS	2.6B	872.0M	-21.10%	10.28%	-109.71	2.96	65.49%	64.15%
HELE	2.3B	2.0B	-14.57%	11.69%	14.42	1.17	-7.82%	10.32%
SMALL-CAP
EPC	1.8B	2.3B	-2.72%	-16.29%	16.84	0.79	4.31%	6.67%
ACU	156.8M	191.5M	7.19%	69.47%	8.81	0.82	-1.27%	486.29%
GROV	54.6M	259.3M	-16.93%	214.00%	-1.26	0.21	-19.36%	50.71%
UG	36.1M	10.9M	2.75%	-17.26%	13.99	3.32	-14.28%	0.46%

Hims & Hers Health, Inc. News

Latest updates

Hims & Hers Health, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Revenue	8.8%	246,619,000	226,699,000	207,912,000	190,770,000	167,203,000	144,836,000	113,563,000	101,314,000	84,699,000	74,173,000	60,692,000	52,314,000	41,466,000	41,324,000	35,904,000	30,063,000	-
Cost Of Revenue	8.0%	42,561,000	39,391,000	37,754,000	37,345,000	34,866,000	30,383,000	26,387,000	26,558,000	22,601,000	19,301,000	13,415,000	12,067,000	9,574,000	10,047,000	10,242,000	9,444,000	-
Gross Profit	8.9%	204,058,000	187,308,000	170,158,000	153,425,000	132,337,000	114,453,000	87,176,000	74,756,000	62,098,000	54,872,000	47,277,000	40,247,000	31,892,000	31,277,000	25,662,000	20,619,000	-
Operating Expenses	4.4%	204,458,000	195,862,000	179,394,000	164,688,000	143,942,000	134,436,000	107,366,000	91,675,000	83,663,000	82,533,000	64,684,000	88,656,000	36,518,000	34,598,000	26,641,000	26,837,000	-
S&GA Expenses	-10.0%	32,319,000	35,907,000	31,144,000	30,513,000	27,568,000	26,246,000	22,567,000	21,811,000	5,786,500	25,190,000	36,740,000	61,698,000	-22,370,000	19,496,000	14,841,000	14,064,000	243,536
EBITDA Margin	57.7%	-0.01	-0.03	-0.05	-0.08	-0.11	-0.18	-0.21	-0.22	-0.39	-0.36	-0.36	-0.36	-0.11	-0.54	-0.62	-0.72	-0.86
Interest Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10,000	-
Income Taxes	46.1%	951,000	651,000	-13,000	386,000	-121,000	-16,000	12,000	94,000	-87,000	-3,173,000	34,000	90,000	24,000	31,000	37,000	35,000	-
Earnings Before Taxes	131.8%	2,196,000	-6,916,000	-7,170,000	-9,681,000	-11,028,000	-18,856,000	-19,667,000	-16,158,000	-31,248,000	-19,114,000	-9,119,000	-51,314,000	-5,205,000	-5,840,000	-944,000	-5,998,000	-
EBT Margin	43.7%	-0.02	-0.04	-0.07	-0.10	-0.12	-0.19	-0.23	-0.24	-0.41	-0.37	-0.37	-0.37	-0.12	-0.54	-0.62	-0.73	-0.87
Net Income	116.5%	1,245,000	-7,567,000	-7,157,000	-10,067,000	-10,907,000	-18,840,000	-19,679,000	-16,252,000	-31,161,000	-15,941,000	-9,153,000	-51,404,000	-5,229,000	-5,871,000	-981,000	-6,033,000	-6,419,439
Net Income Margin	40.0%	-0.03	-0.05	-0.07	-0.10	-0.12	-0.19	-0.22	-0.23	-0.40	-0.36	-0.37	-0.37	-0.12	-0.15	-0.11	-0.12	-0.87
Free Cashflow	-12.7%	21,983,000	25,191,000	16,826,000	9,483,000	-6,688,000	5,985,000	-6,394,000	-19,403,000	-3,105,000	-15,960,000	601,000	-15,948,000	-269,000	3,136,000	-155,000	-5,191,000	-34,482

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																			(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2
Assets	6.6%	441	414	390	376	366	383	380	382	421	420	348	346	119	206	206	206	72.00	204	-
Current Assets	5.9%	265	250	235	226	217	233	230	232	270	274	336	340	113	1.00	1.00	2.00	70.00	2.00	-
Cash Equivalents	66.7%	97.00	58.00	65.00	49.00	47.00	58.00	55.00	48.00	72.00	65.00	107	88.00	28.00	37.00	47.00	55.00	23.00	2.00	-
Inventory	2.1%	22.00	22.00	21.00	21.00	22.00	22.00	20.00	12.00	14.00	11.00	7.00	5.00	4.00	-	-	-	4.00	-	-
Goodwill	0%	111	111	111	111	111	111	111	111	111	111	3.00	-	-	-	-	-	-	-	-
Liabilities	13.9%	97.00	85.00	70.00	64.00	55.00	72.00	61.00	54.00	86.00	65.00	55.00	53.00	16.00	10.00	8.00	8.00	21.00	8.00	-
Current Liabilities	7.2%	88.00	83.00	67.00	56.00	48.00	67.00	56.00	49.00	79.00	52.00	27.00	20.00	15.00	3.00	1.00	1.00	21.00	1.00	1.00
Shareholder's Equity	4.7%	344	329	320	313	312	311	319	328	335	355	293	292	5.00	5.00	5.00	5.00	5.00	5.00	0.00
Retained Earnings	0.3%	-368	-369	-361	-354	-344	-333	-314	-295	-278	-247	-231	-222	-171	0.00	2.00	2.00	-153	0.00	-0.02
Additional Paid-In Capital	2.0%	712	698	682	668	657	645	634	623	614	603	525	515	24.00	5.00	3.00	3.00	13.00	5.00	0.00
Shares Outstanding	0.4%	209	209	208	207	205	205	204	203	187	200	192	153	35.00	35.00	35.00	35.00	35.00	-	-
Float	-	-	-	1,800	-	-	-	840	-	-	-	1,800	-	-	-	205	-	199	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																			(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2
Cashflow From Operations	-12.7%	21,983	25,191	16,826	9,483	-6,719	5,985	-6,394	-19,403	-3,105	-15,960	601	-15,948	-269	3,136	-155	-5,191	-34.48	-207	-
Share Based Compensation	3.0%	17,791	17,277	16,845	14,167	12,350	10,979	10,632	8,856	11,952	11,869	9,160	34,230	1,088	1,414	1,925	1,404	-	-	-
Cashflow From Investing	166.6%	20,695	-31,061	2,373	-4,113	6,003	-2,576	12,819	18,453	10,242	-25,922	22,736	-163,324	-8,082	-24,750	-14,102	7,233	-	-	-
Cashflow From Financing	-154.2%	-3,963	-1,559	-2,541	-3,412	-10,459	-494	353	-22,527	-78.00	-484	-4,340	239,945	-707	12,367	5,747	30,335	-	-	-
Buy Backs	-	-	-	-	-	-	-	-	-	-22,027	-	125	21,902	-	-	-	-	-	-	-

HIMS Income Statement

2023-12-31

Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue	$ 872,000	$ 526,916	$ 271,878
Cost of revenue	157,051	118,194	67,384
Gross profit	714,949	408,722	204,494
Operating expenses:
Marketing	446,435	272,587	135,902
Operations and support	119,857	77,403	47,593
Technology and development	48,227	29,237	22,379
General and administrative	129,883	98,192	113,662
Total operating expenses	744,402	477,419	319,536
Loss from operations	(29,453)	(68,697)	(115,042)
Other income (expense):
Change in fair value of liabilities	(1,075)	70	3,802
Other income, net	8,957	2,918	445
Total other income, net	7,882	2,988	4,247
Loss before income taxes	(21,571)	(65,709)	(110,795)
(Provision) benefit for income taxes	(1,975)	31	3,136
Net loss	(23,546)	(65,678)	(107,659)
Other comprehensive income (loss)	153	(140)	(126)
Total comprehensive loss	$ (23,393)	$ (65,818)	$ (107,785)
Net loss per share attributable to common stockholders:
Basic (in USD per share)	$ (0.11)	$ (0.32)	$ (0.58)
Diluted (in USD per share)	$ (0.11)	$ (0.32)	$ (0.58)
Weighted average shares outstanding:
Basic (in shares)	209,344,712	204,516,120	186,781,537
Diluted (in shares)	209,344,712	204,516,120	186,781,537

HIMS Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 96,663	$ 46,772
Short-term investments	124,318	132,853
Inventory	22,464	21,562
Prepaid expenses and other current assets	21,608	15,408
Total current assets	265,053	216,595
Restricted cash	856	856
Goodwill	110,881	110,881
Property, equipment, and software, net	36,143	11,199
Intangible assets, net	18,574	21,841
Operating lease right-of-use assets	9,588	4,936
Other long-term assets	91	33
Total assets	441,186	366,341
Current liabilities:
Accounts payable	43,070	32,363
Accrued liabilities	28,972	12,448
Deferred revenue	7,733	1,472
Earn-out payable	7,412	0
Operating lease liabilities	1,281	1,658
Total current liabilities	88,468	47,941
Operating lease liabilities	8,667	3,649
Earn-out liabilities	0	2,975
Other long-term liabilities	22	35
Total liabilities	97,157	54,600
Commitments and contingencies (Note 14)
Stockholders' equity:
Common stock – Class A shares, par value $0.0001, 2,750,000,000 shares authorized and 205,104,120 and 200,051,689 shares issued and outstanding as of December 31, 2023 and 2022, respectively; Class V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued and outstanding as of December 31, 2023 and 2022	21	21
Additional paid-in capital	712,307	656,626
Accumulated other comprehensive loss	(124)	(277)
Accumulated deficit	(368,175)	(344,629)
Total stockholders' equity	344,029	311,741
Total liabilities and stockholders' equity	$ 441,186	$ 366,341

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.

CEO	Mr. Andrew Dudum
WEBSITE	forhims.com
INDUSTRY	Household Products
EMPLOYEES	651

Hims & Hers Health, Inc. Frequently Asked Questions

What is the ticker symbol for Hims & Hers Health, Inc.? What does HIMS stand for in stocks?

HIMS is the stock ticker symbol of Hims & Hers Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Hims & Hers Health, Inc. (HIMS)?

As of Thu Apr 18 2024, market cap of Hims & Hers Health, Inc. is 2.58 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HIMS stock?

You can check HIMS's fair value in chart for subscribers.

What is the fair value of HIMS stock?

You can check HIMS's fair value in chart for subscribers. The fair value of Hims & Hers Health, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Hims & Hers Health, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for HIMS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Hims & Hers Health, Inc. a good stock to buy?

The fair value guage provides a quick view whether HIMS is over valued or under valued. Whether Hims & Hers Health, Inc. is cheap or expensive depends on the assumptions which impact Hims & Hers Health, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HIMS.

What is Hims & Hers Health, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 18 2024, HIMS's PE ratio (Price to Earnings) is -109.71 and Price to Sales (PS) ratio is 2.96. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HIMS PE ratio will change depending on the future growth rate expectations of investors.